MENU
+Compare
TRUMF
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$15.29
Change
+$0.19 (+1.26%)
Capitalization
24.36B

TRUMF Terumo Corp. Forecast, Technical & Fundamental Analysis

Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue... Show more

TRUMF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TRUMF with price predictions
Nov 12, 2025

TRUMF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TRUMF turned positive on November 10, 2025. Looking at past instances where TRUMF's MACD turned positive, the stock continued to rise in of 70 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 79 cases where TRUMF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where TRUMF advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 193 cases where TRUMF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TRUMF as a result. In of 154 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

TRUMF moved below its 50-day moving average on November 11, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUMF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.418) is normal, around the industry mean (10.242). P/E Ratio (26.614) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (2.182) is also within normal values, averaging (2.733). Dividend Yield (0.012) settles around the average of (0.016) among similar stocks. P/S Ratio (3.274) is also within normal values, averaging (111.072).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRUMF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRUMF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
TRUMF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

TRUMF paid dividends on December 02, 2020

Terumo Corp. TRUMF Stock Dividends
А dividend of $28.00 per share was paid with a record date of December 02, 2020, and an ex-dividend date of September 29, 2020. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2-44-1 Hatagaya
Phone
+81 333748111
Employees
26482
Web
https://www.terumo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GPZ26.390.22
+0.84%
Vaneck Alternative Asset Manager ETF
QVMS28.060.07
+0.26%
Invesco S&P SmallCp 600 QVM Mlt-fctr ETF
WISE43.290.03
+0.07%
Themes Generative Artificial Int ETF
KXI64.860.01
+0.02%
iShares Global Consumer Staples ETF
SCHX27.00N/A
N/A
Schwab US Large-Cap ETF™

TRUMF and Stocks

Correlation & Price change

A.I.dvisor tells us that TRUMF and SKHHY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRUMF and SKHHY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMF
1D Price
Change %
TRUMF100%
+1.28%
SKHHY - TRUMF
22%
Poorly correlated
+1.73%
ANSLY - TRUMF
20%
Poorly correlated
N/A
SSMXY - TRUMF
9%
Poorly correlated
-0.95%
UEEC - TRUMF
5%
Poorly correlated
+13.08%
VPTDF - TRUMF
3%
Poorly correlated
+0.84%
More

Groups containing TRUMF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMF
1D Price
Change %
TRUMF100%
+1.28%
Pharmaceuticals
category (378 stocks)
-3%
Poorly correlated
-0.99%
Pharmaceuticals: Other
category (103 stocks)
-4%
Poorly correlated
-1.40%